A  group of experts advising the nation’s premier cancer research  institution has recommended changing the definition of cancer and  eliminating the word from some common diagnoses as part of sweeping  changes in the nation’s approach to cancer detection and treatment. The  recommendations, from a working group of the National Cancer Institute,  were published [in] The Journal of the American Medical Association.  They say, for instance, that some premalignant conditions, like one  that affects the breast called ductal carcinoma in situ, which many  doctors agree is not cancer, should be renamed to exclude the word  carcinoma so that patients are less frightened and less likely to seek  what may be unneeded and potentially harmful treatments that can include  the surgical removal of the breast. The group, which includes some of  the top scientists in cancer research, also suggested that many lesions  detected during breast, prostate, thyroid, lung and other cancer  screenings should not be called cancer at all but should instead be  reclassified as IDLE conditions, which stands for “indolent lesions of  epithelial origin.” The impetus behind the call for change is a  growing concern among doctors, scientists and patient advocates that  hundreds of thousands of men and women are undergoing needless and  sometimes disfiguring and harmful treatments for premalignant and  cancerous lesions that are so slow growing they are unlikely to ever  cause harm. Once doctors and patients are aware a lesion  exists, they typically feel compelled to biopsy, treat and remove it,  often at great physical and psychological pain and risk to the patient.
 
No comments:
Post a Comment